1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Isoforms of soluble vascular endothelial growth factor in stress-related mental disorders, 2021, Wallensten et al

Discussion in ''Conditions related to ME/CFS' news and research' started by mango, Apr 23, 2022.

  1. mango

    mango Senior Member (Voting Rights)

    Messages:
    2,525
    Isoforms of soluble vascular endothelial growth factor in stress-related mental disorders: a cross-sectional study

    Johanna Wallensten, Fariborz Mobarrez, Marie Åsberg, Kristian Borg, Aniella Beser, Alexander Wilczek & Anna Nager

    "Abstract

    Vascular endothelial growth factor (VEGF) has been implicated in the pathophysiology of stress-related mental disorders. However, VEGF levels have seldom been compared across mental disorders and never by isoforms.

    Pathophysiological processes involving leakage of astrocyte-derived extracellular vesicles (EVs) across the blood–brain barrier could be associated with VEGF levels in patients with stress-related mental disorders.

    This cross-sectional study compared plasma levels of VEGF121, VEGF165, and VEGF121 + VEGF165 (VEGFtotal) in patients with stress-induced exhaustion disorder (SED) (n = 31), patients with major depressive disorder (MDD) (n = 31), and healthy controls (n = 61).

    It also analyzed the correlation between VEGF and astrocyte-derived EVs in plasma. An enzyme-linked immunosorbent assay (ELISA) was used to measure VEGF121 and VEGF165 in citrate plasma, and flow cytometry was used to measure astrocyte-derived EVs in plasma.

    The mean concentration of soluble VEGF121 (sVEGF121) was significantly higher in patients with SED than healthy controls (P = 0.043). Mean sVEGF165 was significantly lower in patients with MDD than patients with SED (P = 0.004) or healthy controls (P = 0.037). Mean sVEGFtotal was significantly higher in patients with SED than in patients with MDD (P = 0.021) and also higher in patients with SED than healthy controls (P = 0.040).

    Levels of sVEGF121 were positively correlated with levels of astrocyte-derived EVs only in patients with SED (P = 0.0128). The same was true of levels of sVEGFtotal and astrocyte-derived EVs (P = 0.0046).

    Differing levels of VEGF isoforms may reflect different pathophysiological mechanisms in SED and MDD.

    Further research is needed to better understand the potential roles of VEGF isoforms and astrocyte-derived EVs in mental disorders."

    https://www.nature.com/articles/s41598-021-96313-8
     
    Peter Trewhitt likes this.
  2. mango

    mango Senior Member (Voting Rights)

    Messages:
    2,525
    Peter Trewhitt and alktipping like this.
  3. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,469
    Location:
    Canada
    By "stress-related mental disorders" they mean... essentially the ME criteria, framed slightly differently, with the modifier of a "identifiable stressor", except way more vague. So basically it means any illness not explained by a recognized diagnosis.

    I genuinely have no idea how research like this gets funded, using such ridiculous inclusion criteria that they basically mean anything and everything.

    https://www.nature.com/articles/s41598-021-96313-8/tables/1
     
    Peter Trewhitt and Hutan like this.

Share This Page